A novel technique for treating GBM first underwent a phase 1 clinical trial with patients who had recurrence of their cancers ...
Three behavioural phenomena are particularly consequential in screening and prevention research: ...
Moby summary of PDS Biotechnology Corporation's Q4 2025 earnings call ...
In an interview with Targeted Oncology, Pavlos Msaouel, MD, PhD, at The University of Texas MD Anderson Cancer Center ...
PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2025 Earnings Call Transcript March 30, 2026 PDS Biotechnology Corporation beats earnings expectations. Reported EPS is $-0.13, expectations were $-0.2.
Free Malaysia Today on MSN
More women survive cancer but face greater treatment challenges
Recent Australian research shows how biological differences can shape side effects and survival.
Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced it has acquired View Point Medical, Inc. (View Point). Through a merger transaction, View Point is ...
Cancer treatment is undergoing a major transformation driven by advances in precision oncology, in which biomarkers play a central role in guiding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results